期刊文献+

验证超声造影检测透析通路再循环和通路流量

Validation for Access Recirculation and Access Flow Rate Measurement by Contrast-enhanced Ultrasonography During Hemodialysis
原文传递
导出
摘要 本研究旨在验证超声造影(CEUS)检测血液透析通路再循环(AR)和血液透析通路血流量(Qa)的可行性及准确性,分析影响测量准确性的相关因素。通过建立通路循环及透析回路体外管道模型,运用超声造影技术检测动静脉管路的正反接法,针头朝向血流及背向血流等不同情况下对AR及Qa测定的影响。依据指示剂稀释原理计算再循环率R值及Qa,分析测量值与真实值之间的相关性及一致性。结果显示R测量值与R理论值相关性良好(r=0.57,P=0.038,Qa>Qb;r=0.95,P=0.001,Qa<Qb),Bland-altman检验显示测量值与真实值一致性良好,针尖朝向血流绝对错误率(K值)较低。可见CEUS有望成为一项新技术运用于透析AR及Qa的检测。 To evaluate the feasibility and accuracy of contrast-enhanced ultrasonography(CEUS) for the measurement of hemodialysis access recirculation(AR) and access flow rate(Qa),a two pump system was used to simulate access and dialyzer flow.AR and Qa under different conditions,such as reversal connection of dialysis lines and the needle orientation,were compared with each other.The value of access flow and recirculation flow were calculated based on the formulas introduced in this paper,and the correlation and consistency between true flow rate and calculated values were analyzed.The measured R correlated well with true value of flow rate(r=0.57,P=0.038,QaQb;r=0.95,P=0.001,QaQb).The Bland-altman test showed good agreement between the calculated value based on CEUS and true values.The CEUS can be used as a new advanced technology for AR and Qa measurement.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2012年第1期84-88,共5页 Journal of Biomedical Engineering
关键词 验证超声造影 血液透析 通路再循环 通路血流量 Contrast-enhanced ultrasonography(CEUS) Hemodialysis Access recirculation(AR) Access flow rate(Qa)
  • 相关文献

参考文献10

  • 1BESARAB A.Access monitoring is worthwhile and valuable[J].Blood Purif,2006,24(1):77-89.
  • 2WIJNEN E,PLANKEN N,KEUTER X,et al.Impact of aquality improvement programme based on vascular access flowmonitoring on costs,access occlusion and access failure[J].Nephrol Dial Transplant,2006,21(12):3514-3519.
  • 3郁佩青,徐琴君.血管通路再循环影响因素的研究进展[J].中国血液净化,2007,6(10):557-561. 被引量:16
  • 4LINDSAY R M,HUANG S H,STERNBY J,et al.Themeasurement of hemodialysis access blood flow by a conduc-tivity step method[J].Clin J Am Soc Nephrol,2010,5(9):1602-1606.
  • 5BASILE C,RUGGIERI G,VERNAGLIONE L,et al.Acomparison of methods for the measurement of hemodialysisaccess recirculation[J].J Nephrol,2003,16(6):908-913.
  • 6李春伶,高永艳,马秀珠,董继红,陈爽.SonoVue用于诊断腹部病变的价值及安全性[J].中国医学影像技术,2010,26(3):508-510. 被引量:4
  • 7KRIVITSKI N M.Theory and validation of access flow meas-urement by dilution technique during hemodialysis[J].KidneyInt,1995,48(1):244-250.
  • 8ARONSON S,WIENCEK J G,FEINSTEIN S B,et al.As-sessment of renal blood flow with contrast ultrasonography[J].Anesth Analg,1993,76(5):964-970.
  • 9王海燕,王梅主译.美国NKF-K/DOQI[M].北京:人民卫生出版社,2003.478.
  • 10KIM H S,PARK J W,CHANG J H,et al.Early vascularaccess blood flow as a predictor of long-term vascular accesspatency in incident hemodialysis patients[J].J Korean MedSci,2010,25(5):728-733.

二级参考文献28

  • 1赵学智,梅长林.血液透析血管通路的再循环[J].肾脏病与透析肾移植杂志,1995,4(6):573-575. 被引量:11
  • 2Faccioli N, D'Onofrio M, Malago R, et al. Resectable pancreatic adenocarcinoma: iepiction of tumoral margins at contrast-enhanced ultrasonography. Pancreas, 2008,37(3) :265-268.
  • 3Liang P, Wang Y, Zhang D. Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience. J Urol, 2008, 180(3) :844-848.
  • 4Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: retrospective analysis of 23 188 investigations. Ultrasound Med Biol, 2006,32(9) :1369-1375.
  • 5Xu HX, Xie XY, et al. Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radinl, 2008 81(971) :881-889.
  • 6Lu MD, Yu XL, Li AH, et al. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatoeellular carcinoma: a multi-center study in China. Ultrasound Med Biol, 2007,33(11) :1736-1749.
  • 7Bokor D, Chambers JB, Rees PJ, et al. Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Invest Radiol, 2001,36(2):104-109.
  • 8Dai Y, Chen MH, Yin SS, et al. Focal liver lesions: can SonoVueenhanced ultrasound be used to differentiate malignant from benign lesions? Invest Radiol, 2007,42(8) :596-603.
  • 9Bartolotta TV, Taihbi A, Galia M, et al. Characterization of hypoechoic focal hepatic lesions in patients with fatty liver: diagnostic performance and confidence of contrast enhanced ultrasound. Eur Radiol, 2007,17(3) :650-661.
  • 10Rossi F, Leone VF, Vignoli M, et al. Use of contrast-enhanced ultrasound for characterization of focal splenic lesions. Vet Radiol Ultrasound, 2008,49(2) : 154-164.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部